Cargando…

P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY

Detalles Bibliográficos
Autores principales: Ramasamy, Karthik, Goldschmidt, Hartmut, Moreau, Philippe, Petrucci, Maria-Teresa, Kuter, David, Durie, Brian, Cella, David, Dhanda, Devender, Gu, Jin, Amin, Suvina, Marshall, Thomas, Patwardhan, Pallavi, Fish, Susan, Vij, Ravi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431287/
http://dx.doi.org/10.1097/01.HS9.0000970684.64255.5a
_version_ 1785091164903309312
author Ramasamy, Karthik
Goldschmidt, Hartmut
Moreau, Philippe
Petrucci, Maria-Teresa
Kuter, David
Durie, Brian
Cella, David
Dhanda, Devender
Gu, Jin
Amin, Suvina
Marshall, Thomas
Patwardhan, Pallavi
Fish, Susan
Vij, Ravi
author_facet Ramasamy, Karthik
Goldschmidt, Hartmut
Moreau, Philippe
Petrucci, Maria-Teresa
Kuter, David
Durie, Brian
Cella, David
Dhanda, Devender
Gu, Jin
Amin, Suvina
Marshall, Thomas
Patwardhan, Pallavi
Fish, Susan
Vij, Ravi
author_sort Ramasamy, Karthik
collection PubMed
description
format Online
Article
Text
id pubmed-10431287
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104312872023-08-17 P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY Ramasamy, Karthik Goldschmidt, Hartmut Moreau, Philippe Petrucci, Maria-Teresa Kuter, David Durie, Brian Cella, David Dhanda, Devender Gu, Jin Amin, Suvina Marshall, Thomas Patwardhan, Pallavi Fish, Susan Vij, Ravi Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431287/ http://dx.doi.org/10.1097/01.HS9.0000970684.64255.5a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Ramasamy, Karthik
Goldschmidt, Hartmut
Moreau, Philippe
Petrucci, Maria-Teresa
Kuter, David
Durie, Brian
Cella, David
Dhanda, Devender
Gu, Jin
Amin, Suvina
Marshall, Thomas
Patwardhan, Pallavi
Fish, Susan
Vij, Ravi
P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY
title P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY
title_full P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY
title_fullStr P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY
title_full_unstemmed P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY
title_short P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY
title_sort p945: real-world clinical outcomes among triple-class exposed relapsed refractory multiple myeloma patients in us and europe: a preamble registry study
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431287/
http://dx.doi.org/10.1097/01.HS9.0000970684.64255.5a
work_keys_str_mv AT ramasamykarthik p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT goldschmidthartmut p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT moreauphilippe p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT petruccimariateresa p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT kuterdavid p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT duriebrian p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT celladavid p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT dhandadevender p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT gujin p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT aminsuvina p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT marshallthomas p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT patwardhanpallavi p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT fishsusan p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy
AT vijravi p945realworldclinicaloutcomesamongtripleclassexposedrelapsedrefractorymultiplemyelomapatientsinusandeuropeapreambleregistrystudy